Blanket Purchase Agreement 36F79719D0024-36C25023A0057
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company specializing in medical devices, diagnostic products, pharmaceuticals, and nutritional goods. The BPA has a ceiling value of $56,389,609.20 and a performance period from October 1, 2025 to September 30, 2033. The purpose of this BPA is to provide the VA with immunochemistry laboratory cost per reportable result services, which includes the...
- This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 8, to Abbott Laboratories Inc. as the prime contractor. The contract has a total ceiling value of $10,879,562.65 and will run through March 31, 2026. Abbott Laboratories, through its Abbott Diagnostics Division, is providing a range of chemistry automation products and services to support the VA's medical testing capabilities. This includes the...
- This Blanket Purchase Agreement (BPA) contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Abbott Laboratories Inc., a global healthcare company, to provide chemistry immunoassay testing services and supplies. The single-award BPA has a ceiling value of $4,300,000 and a period of performance through September 30, 2026. The contract is a call against Abbott's existing General Services Administration (GSA) Federal Supply Schedule for...
- This Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) to Abbott Laboratories Inc. provides automated chemistry and immunochemistry instrumentation, reagents, and related services to support clinical laboratory operations across VA healthcare facilities. The single-award, firm fixed-price contract, with a total ceiling value of $6,640,812.54, was established under the General Services Administration (GSA)...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 to Abbott Laboratories Inc., a global healthcare company. The BPA has a ceiling value of $3,861,550.32 and a period of performance through June 29, 2027. It was issued under the GSA Federal Supply Schedule for Critical Analyzers and Laboratory Equipment (FSS-66-III), enabling the VA to efficiently procure a variety of SARS-CoV-2 and HIV diagnostic testing...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company specializing in medical devices, diagnostic products, and clinical services. The $99,447.50 contract is a BPA call placed against Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers and Laboratory equipment (FSS-66-III). The...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company and manufacturer of medical devices, diagnostic equipment, pharmaceuticals, and clinical testing technologies. The contract, valued at a ceiling of $1,652,770.00, is for the delivery of i-STAT point-of-care handheld blood analyzers and associated reagents. The BPA, which does not have a set-aside designation, will be used by the VA's...
- This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 to Abbott Laboratories Inc., a global manufacturer of medical devices, diagnostic equipment, and pharmaceuticals. The contract, valued at up to $640,000, provides testing supplies and reagents to support VA healthcare operations across the VISN 1 region. The BPA is associated with Abbott's existing Indefinite Delivery Vehicle (IDV) contract under the GSA's In-Vitro...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, received a single-award Blanket Purchase Agreement valued at $3.56 million from the Department of Veterans Affairs, effective October 1, 2025, through June 30, 2026. The BPA was awarded without set-aside designation under full and open competition and serves as a master contract vehicle under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. This IDV contract procures...
- The Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 to Abbott Laboratories Inc. is for the provision of "TEST KITS FOR IN-PATIENT LABORATORY". The single-award BPA has a ceiling value of $6,690.00 and was originally awarded on December 7, 2010, with a period of performance through December 7, 2010. Two task orders have been issued under this BPA. The first, valued at $3,426.40, was awarded on January 27,...
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- 36F79719D0024Federal Supply Schedule
- 36F79719D0024-36C25023A0057Blanket Purchase Agreement
- 3Federal Contract Awards
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 10, to Abbott Laboratories Inc. The contract has a ceiling value of $36,200,716.50 and a period of performance from September 18, 2023, to September 17, 2026. The primary purpose of this BPA is to provide the delivery, installation, and system configuration services for an automated chemistry analyzer system, including all reagents, consumables, and controls. The contract also includes the option to exercise a second option year. The contract was awarded under the General Services Administration (GSA) Federal Supply Schedule for Critical Analyzers and Laboratory equipment (FSS-66-III), which allows for streamlined procurement of medical technologies by federal agencies. The contract does not have a set-aside designation. Task orders issued under this BPA include the exercise of Option Year 2 for $2,600,297.61, a BPA order for Option Year 1 valued at $12,066,905.50, and the procurement of chemistry and immunology laboratory testing equipment valued at $2,413,381.10.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Exercise an Option | $0 | 9/18/25 | |
| P00005 | Exercise an Option | $0 | 9/17/24 | |
| P00004 | Other Administrative Action | $0 | 7/17/24 | |
| P00003 | Other Administrative Action | $0 | 4/12/24 | |
| P00002 | Other Administrative Action | $0 | 2/2/24 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call 36C25023A0057-36C25024N0957 | Abbott Laboratories Inc. | $12.1m | 9/18/24 | 9/17/25 | 9/17/24 | |
BPA Call 36C25023A0057-36C25025N0894 | Abbott Laboratories Inc. | $2.6m | 9/18/25 | 9/17/26 | 9/18/25 | |
BPA Call 36C25023A0057-36C25023N0802 | Abbott Laboratories Inc. | $2.4m | 9/18/23 | 9/17/24 | 9/18/23 |